Veracyte Reports Q1 2026 Earnings with Strong Revenue and Volume Growth
Veracyte (VCYT) reported Q1 2026 earnings with total revenue of $139.1 million, a 21% year-over-year increase driven by growth in its Decipher and Afirma test franchises. The company performed approximately 47,600 tests, a 17% increase compared to the same period in 2025, and generated $35.2 million in operating cash flow.
Tickers: $VCYT
Topics: gross margin operating cash flow operating expenses revenue testing volume